Active, not recruitingPhase 3NCT05701774

Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome

Studying Prader-Willi syndrome

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Soleno Therapeutics, Inc.
Intervention: DCCR(drug)
Enrollment: 83 enrolled
Eligibility: 4 years · All sexes
Timeline: 2023 – 2028

Study locations (22)

UC Irvine, Orange, California, United States
Stanford University, Palo Alto, California, United States
Rady Children's Hospital of San Diego, San Diego, California, United States
U of Florida Gainesville, Gainesville, Florida, United States
Emory Children's Center, Atlanta, Georgia, United States
Indiana University School of Medicine, Indianapolis, Indiana, United States
National Institutes of Health, Bethesda, Maryland, United States
Boston Children's Hospital, Boston, Massachusetts, United States
Sparrow Clinical Research Institute, Lansing, Michigan, United States
Children's Hospital and Clinic Minnesota, Saint Paul, Minnesota, United States
St. Joseph's University Medical Center, Paterson, New Jersey, United States
NYU Winthrop Hospital, Mineola, New York, United States
The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States
Vanderbilt University, Nashville, Tennessee, United States
Research Institute of Dallas, Dallas, Texas, United States
+7 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05701774 on ClinicalTrials.gov

Other trials for Prader-Willi syndrome

Additional recruiting or active studies for the same condition.

See all trials for Prader-Willi syndrome →

← Back to all trials